CalciMedica, Inc. (CALC)
2.17
-0.03
(-1.36%)
USD |
NASDAQ |
Sep 04, 16:00
2.23
+0.06
(+2.76%)
After-Hours: 20:00
CalciMedica Enterprise Value : 3.923M for Sept. 4, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 04, 2026 | 3.923M |
| September 03, 2026 | 4.107M |
| September 02, 2026 | 3.492M |
| September 01, 2026 | 2.878M |
| August 31, 2026 | 3.738M |
| August 28, 2026 | 4.857M |
| August 27, 2026 | 5.029M |
| August 26, 2026 | 8.641M |
| August 25, 2026 | 8.656M |
| August 24, 2026 | 7.685M |
| August 21, 2026 | 8.189M |
| August 20, 2026 | 8.508M |
| August 19, 2026 | 9.428M |
| August 18, 2026 | 10.19M |
| August 17, 2026 | 10.95M |
| August 14, 2026 | 11.33M |
| August 13, 2026 | 10.79M |
| August 12, 2026 | 9.637M |
| August 11, 2026 | 10.80M |
| August 10, 2026 | 10.84M |
| August 07, 2026 | 11.71M |
| August 06, 2026 | 12.47M |
| August 05, 2026 | 13.36M |
| August 04, 2026 | 15.02M |
| August 03, 2026 | 13.72M |
| Date | Value |
|---|---|
| July 31, 2026 | 21.32M |
| July 30, 2026 | 16.40M |
| July 29, 2026 | 13.41M |
| July 28, 2026 | 12.65M |
| July 27, 2026 | 12.20M |
| July 24, 2026 | 13.94M |
| July 23, 2026 | 12.59M |
| July 22, 2026 | 13.46M |
| July 21, 2026 | 12.41M |
| July 20, 2026 | 12.24M |
| July 17, 2026 | 13.19M |
| July 16, 2026 | 11.91M |
| July 15, 2026 | 14.60M |
| July 14, 2026 | 13.46M |
| July 13, 2026 | 15.72M |
| July 10, 2026 | 19.17M |
| July 09, 2026 | 19.78M |
| July 08, 2026 | 18.25M |
| July 07, 2026 | 19.96M |
| July 06, 2026 | 20.95M |
| July 02, 2026 | 20.26M |
| July 01, 2026 | 22.55M |
| June 30, 2026 | 22.24M |
| June 29, 2026 | 14.08M |
| June 26, 2026 | 11.38M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.871B |
| Corcept Therapeutics, Inc. | 11.75B |
| Veru, Inc. | 21.90M |
| Johnson & Johnson | 691.09B |
| Eli Lilly & Co. | 1.128T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.652M |
| Total Expenses (Quarterly) | 7.652M |
| EPS Diluted (Quarterly) | -2.237 |
| Earnings Yield | -312.8% |
| Normalized Earnings Yield | -299.31 |